Botanix Pharmaceuticals Limited’s Acquisition of Sofpironium Bromide

Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal.Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel, 15%,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now